This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Shelley Bhattacharya: Innovator in Pharmaceutical Composition for Lung Cancer Treatment
Introduction
Shelley Bhattacharya is a notable inventor based in Santiniketan, India. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of lung cancer. Her innovative work has led to the development of a unique synergistic pharmaceutical composition.
Latest Patents
Shelley holds 1 patent for her invention titled "Synergistic pharmaceutical composition useful for the treatment of lung cancer." This invention comprises a combination of Compound C2 (Neo-isopulegol), C3 (Iso-pulegol), and C4 (Citronellol), which are derived from herbal seed extracts. The composition is designed to effectively target and kill A549 lung cancer cells, showcasing the potential of these compounds either alone or in combination.
Career Highlights
Throughout her career, Shelley has worked with esteemed organizations such as the Council of Scientific and Industrial Research and Visva-Bharati. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.
Collaborations
Shelley has collaborated with notable colleagues, including Sushmita Bhattacharya and Priyajit Chatterjee. These partnerships have enriched her research and expanded the impact of her work in the pharmaceutical field.
Conclusion
Shelley Bhattacharya's innovative contributions to lung cancer treatment through her patented pharmaceutical composition highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also offers hope for improved cancer therapies.